Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients
Avadhut D. Joshi, Rachel C. Botham, Lisa J. Schlein, Howard S. Roth, Antonella Mangraviti, Alexandra Borodovsky, Betty Tyler, Steve Joslyn, Jayme S. Looper, Michael Podell, Timothy M. Fan, Paul J. Hergenrother, Gregory J. Riggins
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients'. Together they form a unique fingerprint.